Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sulavik

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genesM C Sulavik, C Houseweart, C Cramer, et al.
Inflammation|August 1, 1991
Hydrogen peroxide-induced cell and tissue injury: protective effects of Mn2+J Varani, I Ginsburg, D F Gibbs, et al.
Journal of Bacteriology|June 3, 2006
Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathwayMichael A D'Elia, Mark P Pereira, Yu Seon Chung, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2007
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groupsMichael D Huband, Michael A Cohen, Margaret Zurack, et al.
Comparative Medicine|February 6, 2008
Development of a mouse model of induced Staphylococcus aureus infective endocarditisGlenn W Gibson, Steven C Kreuser, Janet M Riley, et al.
Journal of Bacteriology|February 13, 2001
Genetic footprinting in bacteriaR S Hare, S S Walker, T E Dorman, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genesM C Sulavik, C Houseweart, C Cramer, et al.
Inflammation|August 1, 1991
Hydrogen peroxide-induced cell and tissue injury: protective effects of Mn2+J Varani, I Ginsburg, D F Gibbs, et al.
Journal of Bacteriology|June 3, 2006
Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathwayMichael A D'Elia, Mark P Pereira, Yu Seon Chung, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2007
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groupsMichael D Huband, Michael A Cohen, Margaret Zurack, et al.
Comparative Medicine|February 6, 2008
Development of a mouse model of induced Staphylococcus aureus infective endocarditisGlenn W Gibson, Steven C Kreuser, Janet M Riley, et al.
Journal of Bacteriology|February 13, 2001
Genetic footprinting in bacteriaR S Hare, S S Walker, T E Dorman, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 3